IP Verse

Egis Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Egis Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag

Patent Number:
EP3626270
Title:
New Use
Applicant:
NOVARTIS AG
Opposition Date:
Jul 8, 2024
Patent Number:
EP3294283
Title:
Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure
Applicant:
NOVARTIS AG
Opposition Date:
Oct 9, 2023
Patent Number:
EP2959894
Title:
S1P Receptor Modulators For Treating Multiple Sclerosis
Applicant:
NOVARTIS AG
Opposition Date:
Jul 11, 2023
Patent Number:
EP2234617
Title:
Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters
Applicant:
JANSSEN PHARMACEUTICA NV
Opposition Date:
Dec 31, 2021
Patent Number:
EP2981271
Title:
Therapeutic Uses Of Empagliflozin
Applicant:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Opposition Date:
Aug 12, 2019

Competitors of Egis Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag

NOVARTIS AG

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

JANSSEN PHARMACEUTICA NV

Want to track Egis Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag?

Feel free to send us a message here and we will get back to you